Additionally, they designed a two-plex imaging model to dynamically image and assess the response to cancer immunotherapy by simultaneously tracking PD-L1 and CD8+ cytotoxic T lymphocytes (CTLs) in vivo (Figure 9). The gene discussed is CD274; the disease is cancer.